G. B. Pant National Institute of Himalayan Environment, Kosi-Katarmal, Almora, 263643, Uttarakhand, India.
Biochemistry and Biotechnology Area, Material Resource Efficiency Division, CSIR-Indian Institute of Petroleum, Dehradun, 248005, Uttarakhand, India.
Chem Biodivers. 2023 Jan;20(1):e202200572. doi: 10.1002/cbdv.202200572. Epub 2022 Dec 27.
Taxus wallichiana Zucc. is a high valued medicinal plant and has been mainly studied for its anti-cancer properties. However, research on its other important biological activities, such as its antimicrobial potential, still needs attention. The focus of the present study is to investigate the antimicrobial activity of secondary metabolites of T. wallichiana needles against 3 different groups of microorganisms, i. e., bacteria, actinobacteria, and fungi. Bioactive compounds from T. wallichiana needles were separated through column chromatography, and, TLC-bioautography. Mobile phases were optimized using Snyder's selectivity triangle. Antimicrobial spots were fractionated and compounds were identified by gas chromatography-mass spectroscopy (GC/MS) and liquid chromatography-mass spectrometry (LC/MS). Functional groups were characterized using Fourier transform infrared spectrometry (FTIR) and nuclear magnetic resonance (NMR) was used to identify the molecular structures. GC/MS and LC/MS data analysis confirm the presence of fatty acids (arachidic acid, behenic acid, palmitic acid, and stearic acid), vitamins (nicotinamide), and alkaloids (cinchonine, timolol), aminobenzamides (procainamide), carbocyclic sugar (myoinositol), and alkane hydrocarbon (hexadecane), having antimicrobial activity in the needles of T. wallichiana. To the best of our knowledge, this is the first report on the isolation and characterization of antimicrobial compounds from the needles of Taxus wallichiana (Himalayan yew). The data obtained from the present study will be supportive to the new drug discoveries in modern medicine with various combinations of medicinal plant's active constituents that can be used for curing many diseases.
喜马拉雅红豆杉(Taxus wallichiana Zucc.)是一种高价值的药用植物,主要因其抗癌特性而受到研究。然而,其其他重要生物活性的研究,如抗菌潜力,仍需要关注。本研究的重点是调查喜马拉雅红豆杉针叶中的次生代谢产物对 3 种不同微生物群(细菌、放线菌和真菌)的抗菌活性。通过柱层析和 TLC-生物自显影法从喜马拉雅红豆杉针叶中分离生物活性化合物。使用 Snyder 选择性三角形优化流动相。通过气相色谱-质谱联用(GC/MS)和液相色谱-质谱联用(LC/MS)对分离的抗菌斑点进行鉴定。通过傅里叶变换红外光谱(FTIR)和核磁共振(NMR)鉴定化合物的官能团,通过 NMR 鉴定分子结构。GC/MS 和 LC/MS 数据分析证实了存在具有抗菌活性的脂肪酸(花生酸、山嵛酸、棕榈酸和硬脂酸)、维生素(烟酰胺)和生物碱(辛可宁、噻吗洛尔)、苯甲酰胺(普鲁卡因酰胺)、碳环糖(肌醇)和烷烃(十六烷)。据我们所知,这是首次从喜马拉雅红豆杉针叶中分离和鉴定具有抗菌活性的化合物。本研究获得的数据将有助于现代医学中新药物的发现,各种药用植物活性成分的组合可用于治疗许多疾病。